DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Gujarat Kidney And Super Speciality Limited — Change in Directors/KMP/SMP/Auditor/RTA

NSE 6d ago·24 Aug 2026, 12:55 pm

Gujarat Kidney And Super Speciality

Gujarat Kidney And Super Speciality Limited has informed stock exchanges about a change in its key management personnel, statutory auditors, and registrars and transfer agents. This notification indicates a reshuffle in the company's leadership and administrative support structure.

For investors, this development is a routine corporate update rather than a fundamental shift in business operations. However, it is important to monitor the new appointments to ensure continuity in governance and compliance, as these roles are critical for the smooth functioning of the company.

Investors should watch for any official announcements detailing the names and backgrounds of the new appointees. This information will help assess the impact of the changes on the company's future strategy and management stability.